bunazosin has been researched along with Heart Disease, Ischemic in 6 studies
bunazosin: structure
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with bunazosin ameliorated this ischemia-related shortening of refractory periods at both the endo- and epicardial sites, with a greater effect seen epicardially (p < 0." | 5.30 | Differences in refractory-period response of canine subendocardium and subepicardium to bunazosin, an alpha1-adrenoceptor antagonist, and propranolol during myocardial ischemia. ( Handa, S; Iwamoto, T; Kusuzaki, S; Takigawa, O; Tanabe, T; Usui, K; Yoshitake, M, 1997) |
| "Treatment with bunazosin ameliorated this ischemia-related shortening of refractory periods at both the endo- and epicardial sites, with a greater effect seen epicardially (p < 0." | 1.30 | Differences in refractory-period response of canine subendocardium and subepicardium to bunazosin, an alpha1-adrenoceptor antagonist, and propranolol during myocardial ischemia. ( Handa, S; Iwamoto, T; Kusuzaki, S; Takigawa, O; Tanabe, T; Usui, K; Yoshitake, M, 1997) |
| "Prazosin and yohimbine were found to produce a significant increase in plasma norepinephrine levels in contrast to bunazosin, which had no significant effect." | 1.29 | Effects of alpha-adrenergic blockade on regional myocardial function in canine ischemic myocardium during beta-adrenergic blockade. ( Kono, M; Morita, S; Rubsamen, R, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanabe, T | 4 |
| Takahashi, K | 2 |
| Usui, K | 3 |
| Kitada, M | 2 |
| Mori, H | 3 |
| Yoshioka, K | 1 |
| Handa, S | 3 |
| Kono, M | 1 |
| Morita, S | 1 |
| Rubsamen, R | 1 |
| Nasa, Y | 1 |
| Yabe, K | 1 |
| Takeo, S | 1 |
| Kusuzaki, S | 1 |
| Yoshitake, M | 1 |
| Takigawa, O | 1 |
| Iwamoto, T | 1 |
| Shinozaki, Y | 1 |
6 other studies available for bunazosin and Heart Disease, Ischemic
| Article | Year |
|---|---|
Effects of bunazosin, a selective alpha 1-blocking agent, and propranolol used alone and in combination on canine ventricular refractoriness and its dispersion during myocardial ischemia.
Topics: Adrenergic alpha-Antagonists; Animals; Coronary Circulation; Dogs; Drug Therapy, Combination; Electr | 1993 |
Effects of sympathetic stimulation, with and without previous alpha 1 and beta adrenoceptor blockade, on refractoriness dispersion in canine heart.
Topics: Adrenergic alpha-Antagonists; Animals; Dogs; Electrophysiology; Heart; Myocardial Ischemia; Proprano | 1994 |
Effects of alpha-adrenergic blockade on regional myocardial function in canine ischemic myocardium during beta-adrenergic blockade.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Coronary Circulation; Dogs; Fema | 1995 |
Beta-adrenoceptor stimulation-mediated preconditioning-like cardioprotection in perfused rat hearts.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-A | 1997 |
Differences in refractory-period response of canine subendocardium and subepicardium to bunazosin, an alpha1-adrenoceptor antagonist, and propranolol during myocardial ischemia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; | 1997 |
Disproportional response between refractory period and blood flow to alpha 1- and beta-adrenoceptor blockade in canine ischemic myocardium.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; | 1998 |